Anticancer Drugs. University of Sulaimani Faculty of Medical Sciences School of Pharmacy Pharmacology & Toxicology Dept.

Similar documents
Anticancer Drugs. Cytotoxic drugs Antineoplastic agents

BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

Anticancer Drugs. Cytotoxic drugs Antineoplastic agents

through the cell cycle. However, how we administer drugs also depends on the combinations that we give and the doses that we give.

"The standard treatment for almost all cancers is surgical removal of the lump."

THE CANCER/MITOSIS CONNECTION

Shyana Sadiq DFM 484: MNT Case Study 33: Esophageal Cancer Treated with Surgery and Radiation 10/14/2013

CANCER TREATMENT. Sent from the Diagnostic Imaging Atlas Page 1 of 5

BIT 120. Copy of Cancer/HIV Lecture

Question #1 Controls on cell growth and division turned on and off

Cancer arises from the mutation of a normal gene. A factor which brings about a mutation is called a mutagen.

CANCER IMMUNOPATHOLOGY. Eryati Darwin Faculty of Medicine Andalas University

1 Introduction. 1.1 Cancer. Introduction

Acute: Symptoms that start and worsen quickly but do not last over a long period of time.

What is cancer? l Cancer is a group of several diseases caused by the abnormal growth of cells.

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)

CELL BIOLOGY - CLUTCH CH CANCER.

COURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour

Understanding the role of ex vivo T cell depletion

Cancer Treatment Using Multiple Chemotheraputic Agents Subject to Drug Resistance

Early Embryonic Development

HEMATOLOGIC MALIGNANCIES BIOLOGY

A factor which brings about a mutation is called a mutagen. Any agent that causes cancer is called a carcinogen and is described as carcinogenic.

The effect of insulin on chemotherapeutic drug sensitivity in human esophageal and lung cancer cells

Cancer Chemotherapy. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan December 2018

Corporate Medical Policy

Relapsed acute lymphoblastic leukemia. Lymphoma Tumor Board. July 21, 2017

Lymphatic System Disorders

DRUGS FOR NEOPLASIA. Chapter 37

Functional Limitations

Use of radiation to kill diseased cells. Cancer is the disease that is almost always treated when using radiation.

609G: Concepts of Cancer Genetics and Treatments (3 credits)

Indolent Lymphomas: Current. Dr. Laurie Sehn

Anti-cancer drugs. Introduction : Body : 1) Alkylating Agents

PATHOBIOLOGY OF NEOPLASIA

Regulating the Cell Cycle. Lesson Overview THINK ABOUT IT. How do cells know when to divide? Review: Why do cells divide?

Cancer. Chapter 31 Lesson 2

Mammary Tumors. by Pamela A. Davol

Indolent Lymphomas. Dr. Melissa Toupin The Ottawa Hospital

Essentials. Oncology Practise Essentials. Oncology Basics. Tutorial 2. Cancer Chemotherapy

Radiation Oncology. Initial Certification Qualifying (Computer-based) Examination: Study Guide for Radiation and Cancer Biology

Lymphoma. What is cancer? What are signs that my cat has lymphoma. How is Lymphoma diagnosed?

CHRONIC LYMPHOCYTIC LEUKEMIA

Part II The Cell Cell Division, Chapter 2 Outline of class notes

It is a malignancy originating from breast tissue

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009

Principles of chemotherapy

Oncolytic Virotherapy: Targeting Cancer Stem Cells

Cancer and Oncogenes Bioscience in the 21 st Century. Linda Lowe-Krentz

3 Ideas Presentation. Anonymous students MK, NM, and AW : Intro to Biological Engineering Design

Understanding Radiation Therapy. For Patients and the Public

NAACR Treatment Webinar Quiz 1

Tumor Immunology. Tumor (latin) = swelling

Christine Batten DFM 484 Cast Study 31 Lymphoma Treated with Chemotherapy

XATMEP (methotrexate) oral solution

Cancer Cell Self Sufficiency in Growth Signals

Liver Tumors. Patient Education. Treatment options 8 4A. About the Liver. Surgical Specialties

CHRONIC MYELOGENOUS LEUKEMIA. By Ting Huai Shi Pd. 6

AP: CELL CYCLE REGULATION

Tumors of the Spleen

SECTION 25-1 REVIEW STRUCTURE. 1. The diameter of viruses ranges from about a. 1 to 2 nm. b. 20 to 250 nm. c. 1 to 2 µm. d. 20 to 250 µm.

Antineoplastic Drugs. Antineoplastic Drugs. Herbal Alert. Pharmacology Chapter 51. Green tea

Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data

Radiation biology. Dr. István Voszka. Department of Biophysics and Radiation Biology. Grotthus (1815) - Draper (1845)

Radiobiology of fractionated treatments: the classical approach and the 4 Rs. Vischioni Barbara MD, PhD Centro Nazionale Adroterapia Oncologica

Chapter 12. Regulation of Cell Division. AP Biology

CONTROL OF CELL DIVISION

Cancer Cells. It would take another 20 years and a revolution in the techniques of biological research to answer these questions.

Cancer Biology How a cell responds to DNA Damage

Introduction to Basic Oncology

MANAGEMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA. BY Dr SUBHASHINI 1 st yr PG DEPARTMENT OF PEDIATRICS

- A cancer is an uncontrolled, independent proliferation of robust, healthy cells.

Connections Between Autoimmune Disease & Cancer

Cancer and Cell Differentiation

ph Dependent Drug Delivery System: Review

Practice of Interferon Therapy

Interventional Oncology Patient Awareness

Mast Cell Tumors in Dogs

Acute myeloid leukemia. M. Kaźmierczak 2016

CELL GROWTH & DIVISION

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College

Prophylactic Cranial Irradiation in Acute Lymphoblastic Leukemia: Is there still an indication? Celine Bicquart, MD Radiation Medicine May 5, 2010

Claudia Adams Barr Program in Innovative Cancer Research Dana-Farber Cancer Institute BARR PROGRAM IMPACT STATEMENTS

Regulation of Cell Division (Ch. 12)

France Carrier, Ph.D. July 14, Chemopotentiation by Low Dose-Fractionated Radiation Therapy

Education and Training Strategy

An update on your support of the Kaplan Cancer Research Fund Swedish Cancer Institute

Optimal Delivery of Chemotherapeutic Agents in Cancer

Adjuvant and neoadjuvant chemotherapy for rectal cancer: Expensive but little gain

Oncology 101. Marianne Davies, RN, APRN Yale Cancer Center September 2006

Therapeutic ratio - An Overview. Past Present Future Prof Ramesh S Bilimaga

LESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2

Chapter 3. Toxicity and the Factors That Modify Toxic Responses

Section 1.1: Causes of Disease - Pathogens

Different Types of Cancer

LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University

September 20, Submitted electronically to: Cc: To Whom It May Concern:

Immune System. Name: Class: Date: Multiple Choice Identify the choice that best completes the statement or answers the question.

Transcription:

University of Sulaimani Faculty of Medical Sciences School of Pharmacy Pharmacology & Toxicology Dept. Anticancer Drugs Prepared by: Hussein A. Muhammad MSc cancer Pharmacology hussein.al-barazanchi@kissr.edu.krd (2016-2017)

ANTICANCER DRUGS Chemotherapeutic agents used to treat malignancies or to control the growth of cancerous cells. Drug therapy may be used alone, or in combination with other treatments such as surgery and/or local radiation therapy. PRICIPLES OF CANCER CHEMOTHERAPY Cancer chemotherapy strives to cause lethal cytotoxic event or apoptosis in the cancer cells that can arrest a tumor s progression. Many of the most effective cytotoxic agents act by damaging DNA (fig.1) and other agents act against metabolic sites essential to cell replication. Ideally, these anticancer drugs should interfere only with cellular processes that are unique to malignant cells. Unfortunately, most of current available anticancer drugs do not specifically recognize neoplastic cells but, rather, affect all kinds proliferating cells, both normal and abnormal. One of the characteristics that distinguish anticancer drugs from other drugs is the frequency and severity of side effects at therapeutic doses. 1

(Fig.1) Examples of chemotherapeutics affecting the availability of DNA and RNA precursors A. Treatment Strategies 1. Goals of treatment : The ultimate goal of chemotherapy is a cure (disease-free survival). A true cure requires eradication of every neoplastic cells. If a cure is not attainable, then the goal becomes control of the disease (stop the cancer from enlarging and spreading). In advance stages of cancer when the control is far from reality then the goal is palliation (alleviation of symptoms and avoidance of life-threatening toxicities). 2

2. Indications for treatment : Chemotherapy is sometimes used when neoplasms are disseminated and are not amenable to surgery. - Adjuvant chemotherapy: Using of chemotherapy as a supplemental treatment to attack micrometastases following surgery and radiation treatment. - Neoadjuvant chemotherapy: Chemotherapy given prior to the surgical procedure in an attempt to shrink the cancer. - Maintenance chemotherapy: Chemotherapy given in lower doses to assist in prolonging a remission. 3- Tumor susceptibility and the growth cycle : Rapidly dividing cells are generally more sensitive to anticancer drugs, whereas nonproliferating cells(those in G0 phase) usually survive the toxic effect of these agents. - Cell-cycle specificity of drugs: Both normal cells and tumor cells go through a growth cycle. Chemotherapeutic agents are effective only in replicating cells, that is those cells that are cycling, are said to be cellcycle specific. Whereas other agents are cell-cycle nonspecific. (Fig. 2) Cell Cycle 3

- Tumor growth rate: The growth rate of most tumors in vivo is initially rapid, but decreases as the tumor size increases because of the unavailability of nutrients and oxygen due to inadequate vascularization. Reducing the tumor burden through surgery or radiation promotes the recruitment of the remaining cells into active proliferation and increases their susceptibility to chemotherapeutic agents. B. Treatment regimens and scheduling Drug dosages are usually calculated on the basis of body surface area, in an effort to tailor the medications to each patient. - Log kill phenomenon: Destruction of cancer cells by chemotherapeutic agents follows first-order kinetics (that is, a given dose of drug destroys a constant fraction of cells). The term log kill is used to describe this phenomenon. For example, a diagnosis of leukemia is generally made when there are about 10 9 (total) leukemic cells. Consequently, if treatment leads to 99.999% kill, then 0.001% of total leukemic cells (10 4 ) remain; this is equivalent to 5-log kill. At this point the patient is asymptomatic, that is the patient in remission. Additional treatment is required to totally eradicate the leukemic cells. - Pharmacologic sanctuary: Leukemic or other tumor cells find sanctuary in tissues; an area that is poorly penetrated by pharmacological agents and therefore is the place in which cancer cell can escape the effects of drug therapy. for example CNS. 4

- Treatment protocols: Combination drug chemotherapy is more successful than single-drug treatment in most of the cancers for which chemotherapy is effective. Advantages of chemotherapy drugs combination: 1- Provide maximal cell killing within the range of tolerated toxicity. 2- Are effective against a broader range of cell lines in the heterogeneous tumor population. 3- May delay or prevent the development of resistant cell lines. C. Problems associated chemotherapy 1- Resistance: Prolonged administration of suboptimal drug doses may lead to mutation and producing resistant cancer cells. 2- Multidrug resistance: This resistance is due to ATP dependent pumping of drugs out of the cells in the presence of P-glycoprotein. (Fig.3) Pumping chemotherapies out of the cells of by P-glycoprotein 3- Toxicity: Normal cells undergoing rapid proliferation (for example, cells of buccal mucosa, bone marrow, GI mucosa, and hair follicles) are affected by chemotherapies. 4- Treatment-induced tumor: Because most antineoplastic agents are mutagens, neoplasm may arise 10 years or more after the original cancer was cured. 5